908 Devices Inc (MASS)
5.82
+0.03
(+0.52%)
USD |
NASDAQ |
Apr 16, 12:55
908 Devices Research and Development Expense (Quarterly): 5.444M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 5.444M |
| September 30, 2023 | 5.537M |
| June 30, 2023 | 5.525M |
| March 31, 2023 | 5.398M |
| December 31, 2022 | 4.662M |
| September 30, 2022 | 4.666M |
| June 30, 2022 | 4.293M |
| March 31, 2022 | 3.905M |
| December 31, 2021 | 3.745M |
| Date | Value |
|---|---|
| September 30, 2021 | 3.302M |
| June 30, 2021 | 3.055M |
| March 31, 2021 | 2.965M |
| December 31, 2020 | 2.282M |
| September 30, 2020 | 1.951M |
| June 30, 2020 | 1.846M |
| March 31, 2020 | 2.156M |
| December 31, 2019 | 1.973M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
1.846M
Minimum
Jun 2020
5.537M
Maximum
Sep 2023
3.688M
Average
3.745M
Median
Dec 2021
Research and Development Expense (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 6.08M |
| Retractable Technologies Inc | 0.1617M |
| Xtant Medical Holdings Inc | 0.492M |
| Asensus Surgical Inc | 8.614M |
| Catheter Precision Inc | -0.011M |